Menene tasirin sihiri da ayyukan urolithin A? Waɗanne samfura ne aka ƙara

 Urolithin A muhimmin sinadari ne mai aiki da kwayoyin halitta wanda ake amfani da shi sosai a fannin magani da kula da lafiya. Sinadari ne da kodan ke samarwa galibi kuma yana da aikin narkar da gudan jini. Tasirin sihiri da ayyukan Urolithin A galibi suna bayyana ne ta fuskoki masu zuwa.

Urolithin A yana hana lalacewar tsoka

1. Inganta haɗakar furotin na tsoka da kuma kunna hanyar siginar mTOR

Manufar dabbobin da ke amfani da hanyar siginar rapamycin (mTOR) ita ce babbar hanyar daidaita tsarin samar da sunadaran tsoka. Urolithin A na iya kunna hanyar siginar mTOR da kuma haɓaka haɗakar sunadaran a cikin ƙwayoyin tsoka.

mTOR na iya jin sigina kamar abubuwan gina jiki da abubuwan da ke haifar da ci gaba a cikin ƙwayoyin halitta. Idan aka kunna shi, zai fara jerin ƙwayoyin sigina na ƙasa, kamar furotin ribosomal S6 kinase (S6K1) da furotin eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Urolithin A yana kunna mTOR, yana phosphorylation na S6K1 da 4E-BP1, ta haka yana haɓaka fara fassarar mRNA da haɗuwa da ribosome, da kuma hanzarta haɗa furotin.

Misali, a gwaje-gwajen da aka yi da ƙwayoyin tsoka masu girma a cikin vitro, bayan ƙara urolithin A, an lura cewa matakan phosphorylation na mTOR da ƙwayoyin siginar da ke ƙasa sun ƙaru, kuma bayyanar alamun haɗa furotin tsoka (kamar sarkar nauyi ta myosin) ta ƙaru.
Yana daidaita bayyanar takamaiman ƙwayoyin rubutu na tsoka

Urolitin A zai iya daidaita bayyanar abubuwan da suka shafi ƙwayoyin tsoka waɗanda suke da mahimmanci ga haɗakar furotin tsoka da bambancewar ƙwayoyin tsoka. Misali, yana iya ƙara yawan bayyanar sinadarin bambancin myogenic (MyoD) da myogenin.

MyoD da Myogenin na iya haɓaka bambancin ƙwayoyin tsoka zuwa ƙwayoyin tsoka da kuma kunna bayyanar kwayoyin halitta na musamman na tsoka, ta haka ne ke haɓaka haɗakar furotin na tsoka. A cikin samfurin atrophy na tsoka, bayan maganin urolithin A, bayyanar MyoD da Myogenin ya ƙaru, wanda ke taimakawa wajen kiyaye yawan tsoka da kuma hana raguwar tsoka.

2. Hana lalacewar furotin na tsoka da kuma hana tsarin ubiquitin-proteasome (UPS)

UPS yana ɗaya daga cikin manyan hanyoyin da ke haifar da lalacewar furotin na tsoka. A lokacin raguwar tsoka, ana kunna wasu ligases na ubiquitin E3, kamar su atrophy na tsoka F-box protein (MAFbx) da tsoka RING finger protein 1 (MuRF1), waɗanda za su iya yiwa furotin na tsoka alama da ubiquitin sannan su lalata su ta hanyar proteasome.

Urolithin A na iya hana bayyanar da ayyukan waɗannan ligases na ubiquitin E3. A cikin gwaje-gwajen samfurin dabbobi, urolithin A na iya rage matakan MAFbx da MuRF1, rage alamar ubiquitination na sunadaran tsoka, ta haka yana hana lalacewar furotin tsoka da UPS ke haifarwa da kuma hana raguwar tsoka yadda ya kamata.

Daidaita tsarin autophagy-lysosomal (ALS)

ALS yana taka rawa wajen sabunta sunadaran tsoka da kuma organelles, amma yawan aiki na iya haifar da raguwar tsoka. Urolithin A na iya daidaita ALS zuwa matakin da ya dace. Yana iya hana yawan autophagy da kuma hana lalacewar sunadaran tsoka da yawa.
Misali, urolithin A na iya daidaita yadda furotin ke bayyana a cikin sel masu alaƙa da autophagy (kamar LC3-II), ta yadda zai iya kiyaye yanayin yanayin ƙwayoyin tsoka yayin da yake guje wa wuce gona da iri na sunadaran tsoka, ta haka yana taimakawa wajen kiyaye yawan tsoka.

3. Inganta metabolism na makamashi na ƙwayoyin tsoka

Matsewar tsoka yana buƙatar kuzari mai yawa, kuma mitochondria shine babban wurin samar da makamashi. Urolithin A na iya haɓaka aikin mitochondria na ƙwayoyin tsoka da inganta ingancin samar da makamashi. Yana iya haɓaka biogenesis na mitochondria da ƙara yawan mitochondria.

Misali, urolithin A na iya kunna peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), wanda shine babban mai kula da biogenesis na mitochondrial, yana haɓaka kwafi na DNA na mitochondrial da haɗin furotin masu alaƙa. A lokaci guda, urolithin A kuma na iya inganta aikin sarkar numfashi ta mitochondrial, ƙara haɗa adenosine triphosphate (ATP), samar da isasshen kuzari don matsewar tsoka, da kuma rage raguwar tsoka da rashin isasshen kuzari ke haifarwa.

Yana daidaita metabolism na sukari da lipid kuma yana tallafawa aikin tsoka

Urolithin A na iya daidaita tsarin glucose da lipid metabolism na ƙwayoyin tsoka. Dangane da tsarin glucose metabolism, yana iya haɓaka ɗaukar glucose da amfani da ƙwayoyin tsoka, da kuma tabbatar da cewa ƙwayoyin tsoka suna da isasshen makamashi ta hanyar kunna hanyar siginar insulin ko wasu hanyoyin siginar da suka shafi jigilar glucose.

Dangane da metabolism na lipid, urolithin A na iya haɓaka iskar oxygen a cikin kitse, yana samar da wani tushen kuzari don matsewar tsoka. Ta hanyar inganta metabolism na glucose da lipid, urolithin A yana kula da samar da makamashi ga ƙwayoyin tsoka kuma yana taimakawa hana raguwar tsoka.

Urolithin A yana inganta metabolism

1. Daidaita tsarin metabolism na sukari da kuma inganta yanayin insulin
Urolithin A na iya ƙara yawan sinadarin insulin, wanda yake da mahimmanci don kiyaye daidaiton sukari a jini. Yana iya aiki akan manyan ƙwayoyin halitta a cikin hanyar siginar insulin, kamar furotin masu karɓar insulin (IRS).

A yanayin juriyar insulin, ana hana tyrosine phosphorylation na furotin IRS, wanda ke haifar da gazawar hanyar siginar phosphatidylinositol 3-kinase (PI3K) da ke ƙasa don kunnawa akai-akai, kuma martanin tantanin halitta ga insulin ya ragu.

Urolithin A na iya haɓaka tyrosine phosphorylation na furotin IRS, ta haka yana kunna hanyar siginar PI3K-protein kinase B (Akt), yana ba ƙwayoyin halitta damar shan glucose da amfani da shi sosai. Misali, a cikin gwaje-gwajen samfurin dabbobi, bayan shan urolithin A, an inganta yanayin tsoka da nama mai kitse ga insulin sosai, kuma an sarrafa matakan sukari na jini yadda ya kamata.

Yana daidaita tsarin glycogen da kuma raguwa

Glycogen shine babban nau'in ajiyar glucose a cikin jiki, wanda galibi ana adana shi a cikin hanta da tsokoki. Urolithin A na iya daidaita tsarin hadawa da rugujewar glycogen. Yana iya kunna glycogen synthase, yana haɓaka haɗakar glycogen, da kuma ƙara yawan ajiyar glycogen.

A lokaci guda, urolithin A kuma zai iya hana ayyukan enzymes na glycogenolytic, kamar glycogen phosphorylase, da kuma rage yawan glycogen da ya tarwatse ya zama glucose sannan ya saki cikin jini. Wannan yana taimakawa wajen daidaita matakan sukari na jini da kuma hana yawan canjin sukari a cikin jini. A cikin wani bincike na samfurin masu ciwon suga, bayan maganin urolithin A, yawan glycogen da ke cikin hanta da tsokoki ya ƙaru, kuma an inganta sarrafa sukari a cikin jini.

2. Inganta metabolism na lipid da kuma hana hada sinadarin fatty acid

Urolithin A yana da tasiri mai hana lipids shiga cikin tsarin hada lipids. A cikin hanta da kyallen mai, yana iya hana manyan enzymes a cikin hada fatty acid, kamar fatty acid synthase (FAS) da acetyl-CoA carboxylase (ACC).

FAS da ACC muhimman enzymes ne masu daidaita tsarin hada sinadarin fatty acids. Urolithin A na iya rage hada sinadarin fatty acids ta hanyar hana su aiki. Misali, a cikin tsarin hanta mai kitse da abinci mai yawan kitse ke haifarwa, urolithin A na iya rage aikin FAS da ACC a cikin hanta, rage hada sinadarin triglycerides, ta haka ne zai rage taruwar lipids a cikin hanta.

Yana inganta iskar shaka ta fatty acid

Baya ga hana haɗakar fatty acid, urolithin A kuma yana iya haɓaka rugujewar oxidative na fatty acids. Yana iya kunna hanyoyin sigina da enzymes da suka shafi oxidation na fatty acid. Misali, yana iya ƙara yawan aikin carnitine palmitoyltransferase-1 (CPT-1).

CPT-1 muhimmin enzyme ne a cikin sinadarin β-oxidation na fatty acid, wanda ke da alhakin jigilar fatty acids zuwa mitochondria don rugujewar oxidative. Urolithin A yana haɓaka β-oxidation na fatty acids ta hanyar kunna CPT-1, yana ƙara yawan amfani da kitse, yana taimakawa rage ajiyar kitse a jiki, da kuma inganta metabolism na lipid.

3. Inganta metabolism na makamashi da haɓaka aikin mitochondrial

Mitochondria su ne "masana'antun makamashi" na ƙwayoyin halitta, kuma urolithin A na iya haɓaka aikin mitochondria. Yana iya daidaita biogenesis na mitochondrial da haɓaka haɗakar mitochondrial da sabuntawa. Misali, yana iya kunna peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α).

PGC-1α muhimmin abu ne da ke daidaita yanayin halittar mitochondrial, wanda zai iya haɓaka kwafi na DNA na mitochondrial da kuma haɗa sunadaran da ke da alaƙa da mitochondria. Urolithin A yana ƙara yawan mitochondria da ingancinsa kuma yana inganta yadda ƙwayoyin halitta ke samar da makamashi ta hanyar kunna PGC-1α. A lokaci guda, urolithin A kuma yana iya inganta aikin sarkar numfashi na mitochondria da kuma ƙara haɗa adenosine triphosphate (ATP).

4. Daidaita Sake Tsarin Tsarin Halittar Kwayoyin Halitta

Urolithin A na iya jagorantar ƙwayoyin halitta don yin sake tsara tsarin metabolism, wanda ke sa metabolism na ƙwayar ta fi inganci. A ƙarƙashin wasu yanayi na damuwa ko cututtuka, tsarin metabolism na ƙwayar ta na iya canzawa, wanda ke haifar da raguwar inganci a samar da makamashi da kuma haɗakar abubuwa.

Urolithin A na iya daidaita hanyoyin siginar metabolism a cikin ƙwayoyin halitta, kamar hanyar siginar furotin kinase (AMPK) da aka kunna ta AMP. AMPK "firikwensin" ne na metabolism na makamashin tantanin halitta. Bayan urolithin A ya kunna AMPK, yana iya sa ƙwayoyin halitta su canza daga anabolism zuwa catabolism, yana ƙara amfani da makamashi da abubuwan gina jiki, ta haka ne inganta aikin metabolism gaba ɗaya.

Amfani da urolithin A ba wai kawai a fannin likitanci ba ne. Haka kuma a hankali yana jan hankalin kayayyakin lafiya da kayan kwalliya. Ana ƙara Urolithin A a cikin kayayyakin lafiya da yawa don haɓaka garkuwar jiki, inganta zagayawar jini da kuma haɓaka metabolism. Waɗannan samfuran galibi suna cikin nau'ikan capsules, allunan ko ruwa, waɗanda suka dace da buƙatun ƙungiyoyi daban-daban na mutane.

A fannin kayan kwalliya, ana amfani da urolithin A sosai a cikin kayayyakin kula da fata saboda sabunta ƙwayoyin halitta da kuma tasirin hana tsufa. Yana iya inganta zagayawar jini a cikin fata da kuma haɓaka haɗakar collagen, ta haka yana inganta laushi da haske na fata. Yawancin manyan kamfanonin kula da fata sun fara amfani da urolithin A a matsayin babban sinadari don ƙaddamar da samfuran hana tsufa, gyarawa da danshi don biyan buƙatun masu amfani da su na samun kyakkyawar fata.

A ƙarshe, a matsayin wani sinadari mai aiki da sinadarai masu yawa, urolithin A ya nuna fa'idodi da yawa na amfani a fannonin magani, kiwon lafiya da kyau. Tare da zurfafa binciken kimiyya, fannin amfani da urolithin A zai ci gaba da faɗaɗa, yana samar da ƙarin zaɓuɓɓuka don lafiyar mutane da kyawunsu.